– Morgan Stanley 15th Annual Global Healthcare Conference on 13 September –
– Leerink Partners Rare Disease Immuno-Oncology Roundtable Series on 27 September –
London, UK, 5 Sept 2017: GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that GW executive management will be presenting at the Morgan Stanley 15th Annual Global Healthcare Conference on Wednesday, 13 September 2017 at 11:05 a.m. EDT at the Grand Hyatt Hotel in New York City and the Leerink Partners Rare Disease Immuno-Oncology Roundtable Series on Wednesday, 27 September 2017 at 2:30 p.m. EDT at the Lotte New York Palace in New York City.
A live audio webcast of the presentations will be available through GW’s corporate website at www.gwpharm.com on the Investors section under Events Presentations. A replay will be available soon after the live
... read more at: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=241509